Related Experiment Videos
Proteomic analysis of ubiquitin-proteasome effects: insight into the function of eukaryotic initiation factor 5A
Bao-Feng Jin1, Kun He, Hong-Xia Wang
1Institute of Basic Medical Sciences, National Center of Biomedical Analysis, 27 Tai-Ping Road, Beijing 100850, China.
Abstract:
The global effect of ubiquitin-proteasome (UP) inhibitors on leukemic cell proteome was analysed. A total of 39 protein spots, affected by UP inhibitors, were identified, including 11 new apoptosis-associated proteins. They are involved in different cellular functions and four were associated with caspase-3 activation. Eukaryotic initiation factor 5A (eIF-5A) was identified in two spots; however, the peptide mass-fingerprinting for the accumulated one included a peptide with lysine50, indicating that hypusine formation was suppressed during UP inhibitor-induced apoptosis. Hypusine modification ensues immediately following translation of eIF-5A precursor, unless cells are treated with the modification inhibitors diaminoheptane. However, UP inhibitors induced a much stronger accumulation of unmodified eIF-5A compared to the effect of diaminoheptane. We further showed the unmodified eIF-5A was regulated in a proteasome-dependent manner. Inhibition of hypusine formation by diaminoheptane triggered apoptosis, but of particular interest is the finding that eIF-5A expression inhibition by antisense oligodeoxynucleotides significantly enhanced the stimulating effect of GM-CSF on cell growth. Therefore, the eIF-5A accumulation played important roles in the apoptosis induced by UP inhibitors. Moreover, hypusine inhibition in apoptosis was further revealed to be associated with the subcellular localization of eIF-5A. Our data pave the way to a better understanding of the mechanisms by which UP system has been linked to apoptosis.
Insights
Ubiquitin-proteasome inhibitors trigger apoptosis in leukemic cells by affecting protein levels. Unmodified eukaryotic initiation factor 5A (eIF-5A) accumulation is key to this process.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- The ubiquitin-proteasome (UP) system regulates protein degradation and is implicated in cancer.
- Understanding UP inhibitor mechanisms is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the global proteomic changes induced by UP inhibitors in leukemic cells.
- To elucidate the role of eukaryotic initiation factor 5A (eIF-5A) in UP inhibitor-induced apoptosis.
Main Methods:
- Proteomic analysis using 2D gel electrophoresis and peptide mass fingerprinting.
- Investigating protein modifications like hypusination.
- Utilizing antisense oligodeoxynucleotides and GM-CSF treatments.
Main Results:
- Identified 39 protein spots affected by UP inhibitors, including 11 novel apoptosis-associated proteins.
- Observed suppressed hypusine formation and accumulation of unmodified eIF-5A during UP inhibitor-induced apoptosis.
- Demonstrated that unmodified eIF-5A is regulated by the proteasome and plays a role in apoptosis.
Conclusions:
- UP inhibitors induce apoptosis through proteomic alterations, notably affecting eIF-5A.
- eIF-5A hypusination and subcellular localization are linked to UP inhibitor-induced apoptosis.
- These findings offer insights into the UP system's role in apoptosis and potential therapeutic strategies.